Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Dezember 2020 08:53 ET | Quelle: Research and Markets

Global Multiple Sclerosis Therapies Report 2020-2025

Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
22. Oktober 2020 01:08 ET | Quelle: Research and Markets

Neurodegenerative Disorder Therapeutics Market, 2030 - Development of Novel therapies for Neurodegenerative Disorders through Gene and Cell Therapies

Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) -- The "Global Neurodegenerative Disorder Therapeutics Market: Focus on Product, Mechanism, Route of Administration, Indication, Country Data (14 Countries),...
12. September 2019 05:00 ET | Quelle: Biogen Inc.

New Research Demonstrate Biogen’s Continued Commitment to Improve Care of Patients with Multiple Sclerosis Across Treatment Spectrum

Data highlight benefits of TYSABRI® (natalizumab) treatment in early multiple sclerosis for achieving NEDA (no evidence of disease activity) and improving disability and cognitionAn analysis of data...